adrenaline (epinephrine) acid tartrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
XYLOCAINE 0.5% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12008
Active ingredients:
adrenaline (epinephrine) acid tartrate
lidocaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
22 Dec 2021
to
31 Dec 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Other strengths available.
XYLOCAINE 2% WITH ADRENALINE 1:200,000 20mL injection vial
AUST R: 12021
Active ingredients:
adrenaline (epinephrine) acid tartrate
lidocaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Aspen Pharmacare Australia Pty Ltd

Phone:
1300659646

From
19 Oct 2023
to
01 Jun 2024

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An unregistered product has been approved for supply under Section 19A.The approval holder, Reach Pharmaceuticals can be contacted for details on supply on: 0422 429 648
SEPTANEST 1:200,000 articaine HCl 4% with adrenaline 1:200,000 solution for injection 2.2 mL cartridge
AUST R: 271232
Active ingredients:
adrenaline (epinephrine) acid tartrate
articaine hydrochloride

Dosage form:
Injection, solution

Sponsor:
Specialites Septodont Pty Ltd

Phone:
0432292770

From
13 Nov 2023
to
10 Mar 2024

Shortage status:
Resolved

Availability:
Available

Reason:
Unexpected increase in demand due to other sponsors unable to supply